Beacon Pharmaceuticals PLC announced that the Board of Directors has appointed Mr. Md. Jalal Uddin, FCA as Chief Financial Officer of the company with effect from June 06, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
181.8 BDT | -2.99% | +0.39% | -25.80% |
1st Jan change | Capi. | |
---|---|---|
-25.80% | 394M | |
+18.67% | 43.74B | |
+24.05% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.16% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- BEACONPHAR Stock
- News Beacon Pharmaceuticals PLC
- Beacon Pharmaceuticals PLC Announces Appointment of Jalal Uddin as Chief Financial Officer